DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas

Completed · Phase 1

Conditions studied: Brain and Central Nervous System Tumors, Lymphoma, Unspecified Childhood Solid Tumor, Protocol Specific

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of DX-8951f in treating children who have advanced solid tumors or lymphomas that have not responded to previous therapy.

Key facts

Study ID

NCT00004212

Run by

Daiichi Sankyo

Starts

1999-09-01

Expected to finish

2004-04-01

Last updated by the study team

2012-05-16

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States
• St. Jude Children's Research Hospital — Memphis, Tennessee, United States
• Children's Medical Center of Dallas — Dallas, Texas, United States
• Institute for Drug Development — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.